 |
Video: What is a Stock Split?
|
 |
Champions Oncology is engaged in drug discovery and development through research strategies and pharmacology, biomarker and data platforms. Co.'s research services utilize its research center to assist pharmaceutical and biotechnology companies with their drug development process. Co.'s Software as a service business is centered around its proprietary software platform and data tool, Lumin Bioinformatics, which contains information derived from its research services and clinical studies. Co.'s drug discovery and development business utilizes the computational and experimental capabilities within its platforms. According to our CSBR split history records, Champions Oncology has had 1 split. | |
 |

Champions Oncology (CSBR) has 1 split in our CSBR split history database. The split for CSBR took place on August 12, 2015. This was a 1 for 12 reverse split, meaning for each 12 shares of CSBR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.
When a company such as Champions Oncology conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CSBR split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Champions Oncology shares, starting with a $10,000 purchase of CSBR, presented on a split-history-adjusted basis factoring in the complete CSBR split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/17/2015 |
|
End date: |
02/12/2025 |
|
Start price/share: |
$4.44 |
|
End price/share: |
$10.99 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
147.52% |
|
Average Annual Total Return: |
9.49% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,747.36 |
|
Years: |
9.99 |
|
|
 |
Date |
Ratio |
08/12/2015 | 1 for 12 |
|
 |